With eyes on a poly­mer em­pire prize, French medtech play­er seals $42M in fresh fund­ing

Sur­geons are lim­it­ed by su­tures, wires and sta­ples to re­con­nect tis­sue dur­ing surgery — dou­bly so in min­i­mal­ly in­va­sive pro­ce­dures. Sealants of­fer the promise of re­pair, es­pe­cial­ly for soft tis­sues, like the kind in the lungs or heart. But ex­ist­ing prod­ucts are nei­ther elas­tic nor ad­he­sive enough. En­ter Paris-based medtech play­er Tis­si­um, which claims it has just the fix with a poly­mer that promis­es to do its job on-de­mand, and maybe even de­liv­er drugs — us­ing tech­nol­o­gy orig­i­nal­ly de­vel­oped in the pro­lif­ic lab of MIT’s Bob Langer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER